Effects of intrarenal administration of the COX-2 inhibitor parecoxib during porcine suprarenal aortic cross-clamping

Shock

Volumn 24, Issue 5, 2005, Pages 476-481

  Hauser, Balázs ^a,b   Fröba, Gebhard ^a   Bracht, Hendrik ^a   Sträter, Jörn ^a   Chkhouta, Archil B ^a   Vassilev, Damian ^a   Schoaff, Michael J ^a   Huber Lang, Markus ^a   Brückner, Uwe B ^a   Radermacher, Peter ^a   Schelzig, Hubert ^a,c  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

Aortic surgery; Arachidonic acid pathway; Intra arterial drug perfusion; Ischemia reperfusion; Oxidative stress; Renal protection

Indexed keywords

CREATININE; CYCLOOXYGENASE 2 INHIBITOR; LACTIC ACID; PARECOXIB;

ANIMAL EXPERIMENT; AORTA CLAMPING; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG EFFECT; FEMALE; HEMODYNAMICS; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY METABOLISM; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OXIDATIVE STRESS; OXYGEN CONSUMPTION; RENAL ARTERY; SWINE;

ANGIOGRAPHY; ANIMALS; AORTA; AORTIC ANEURYSM, ABDOMINAL; ARACHIDONIC ACID; CREATININE; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; FEMALE; HEMODYNAMIC PROCESSES; ISOXAZOLES; KIDNEY; MALE; PROSPECTIVE STUDIES; REGIONAL BLOOD FLOW; RENAL CIRCULATION; REPERFUSION INJURY; SWINE; TIME FACTORS;

EID: 27644510400     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000183433.24716.83     Document Type: Article

References (35)

1. Myers BD, Miller DC, Mehigan JT, Olcott C, Golbetz H, Robertson CR, Derby G, Spencer R, Friedman S: Nature of the renal injury following total renal ischemia in man. J Clin Invest 73:329-341, 1984.
2. Sasaki T, Ohsawa S, Ogawa M, Mukaida M, Nakajima T, Komoda K, Tachieda R. Niinuma H, Kawazoe K: Postoperative renal function after an abdominal aortic aneurysm repair requiring a suprarenal aortic cross-clamp. Surg Today 30:33-36, 2000.
3. Hamerlijnek R, De Geest R, Brutel de la Rivière A, Defauw J, Knaepen P, Vermeulen F: Surgical correction of descending thoracic aortic aneurysms with shunt or bypass techniques versus simple aortic cross-clamping. Eur J Cardiothorac Surg 3:37-43, 1989.
4. Allen BT, Anderson CB, Rubin BG, Flye MW, Baumann DS, Sicard GA: Preservation of renal function in suprarenal and suprarenal abdominal aortic aneurysm repair. J Vasc Surg 17:948-958, 1993.
5. Jacobs MJ, Eijsman L, Meylaerts SA, Balm R, Legemate DA, de Haan P, Kalkman CJ, de Mol BA: Reduced renal failure following thoracoabdominal aortic aneurysm repair by selective perfusion. Eur J Cardiothorac Surg 14:201-205, 1998.
6. Morishita K, Yokoyama H, Inoue S, Koshino T, Tamiya Y, Abe T: Selective visceral and renal perfusion in thoracoabdominal aneurysm repair. Eur J Cardiothorac Surg 15:502-507, 1999.
7. Deriu GP, Grego F, Lepidi S, Antonello M, Milite D, Zaramella M, Damiani N: Short-term arterial blood reperfusion of normothermic kidney in renal artery and abdominal aortic reconstructive surgery. Eur J Vasc Endovasc Surg 21:314-319, 2001.
8. Gaazka Z, Świercz P, Rongies W, Szmidt J: Aneurysm of common and internal iliac arteries 14 years after kidney transplantation: a case report. Ann Transplant 7:22-24, 2002.
9. Kotake Y, Yamamoto M, Matsumoto M, Morisaki H, Takeda J: Sivelestat, a neutrophil elastase inhibitor, attenuates neutrophil priming after hepatoenteric ischemia in rabbits. Shock 23:156-160, 2005.
10. Cuzzocrea S, Di Paola R, Mazzon E, Genovese T, Muia C, Caputi AP: WY 14643, a potent exogenous PPAR-á ligand, reduces intestinal injury associated with splanchnic artery occlusion shock. Shock 22:340-346, 2004.
11. Abdelrahman M, Sharples EJ, McDonald MC, Collin M, Patel NS, Yaqoob MM, Thiemermann C: Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemia. Shock 22:63-69, 2004.
12. Mazzon E, Dugo L, De SA, Li JH, Caputi AP, Zhang J, Cuzzocrea S: Beneficial effects of GPI6150, an inhibitor of poly (ADP- ribose) polymerase in a rat model of splanchnic artery occlusion and reperfusion. Shock 17:222-227, 2002.
13. Arumugam TV, Shiels IA, Woodruff TM, Granger DN, Taylor SM: The role of complement system in ischemia-reperfusion injury. Shock 21:401-109, 2004.
14. Harris RC, Breyer MD: Physiological regulation of cyclooxygenase 2 in the kidney. Am J Physiol Renal Physiol 281:F1-F11, 2001.
15. Komers R, Anderson S, Epstein M: Renal and cardiovascular effect of selective cyclooxygenase-2 inhibitors. Am J Kidney Dis 38:1145-1157, 2001.
16. Komers R, Lindsley JN, Oyama TT, Schutzer WE, Reed JF, Mader SL, Anderson S: Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes. J Clin Invest 107:889-899, 2001.
17. Kramer BK, Kammerl MC, Komhoff M: Renal cyclooxygenase-2 (COX-2). Physiological, pathophysiological, and clinical implications. Kidney Blood Press Res 27:43-62, 2004.
18. Selkurt EE: Analysis of intrarenal fluid flux during brief renal ischemia. Am J Physiol 227:1371-1379, 1974.
19. Therland KL, Stubbe J, Thiesson HC, Ottosen PD, Walter S, Sorensen GL, Skott O, Jensen BL: Cyclooxygenase-2 is expressed in vasculature of normal and ischemic adult human kidney and is colocalized with vascular prostaglandin E2 EP4 receptors. J Am Soc Nephrol 15:1189-1199, 2004.
20. Abendroth D, Schelzig H, Mickley V, Storck M: Long-term effect of cyclooxygenase inhibition with acetylsalicylic acid in cadaveric renal transplants. Transpl Proc 29:3004-3005, 1997.
21. Candelario-Jalil E, Álvarez D, González-Falcón, Garcia-Cabrera M, Martínez-Sánchez G, Merino N, Giuliani A, Leon OS: Neuroprotective efficacy of nimesulide against hippocampal neuronal damage following transient forebrain ischemia. Eur J Pharmacol 453:189-195, 2002.
22. Candelario-Jalil E, Gonzülez-Falcón, García-Cabrera M, Álvarez D, Al-Dalain S, Martínez G, León AO, Springer JE: Assessment of the relative contribution of COX-1 and COX-2 isoforms to ischemia-induced oxidative damage and neurodegeneration following transient global cerebral ischemia. J Neurochem 86:545-555, 2003.
23. Jain KK: Evaluation of intravenous parecoxib for the relief of acute postsurgical pain. Expert Opin Investig Drugs 9:2717-2723, 2002.
24. Talley JJ, Bertenshaw SR, Brown DL, Carter JS, Graneto MJ, Kellogg MS, Koboldt CM, Yuan J, Zhang YY, Siebert K: N-([(5-methyl-3-phenylisoxazol-4-yl)- phenyl]sulfonyl}propanamide, sodium salt, parecoxib sodium: a potent and selective inhibitor of COX-2 for parenteral administration. J Med Chem 43:1661-1663, 2000.
25. Furberg CD, Psaty BM, Fitzgerald GA: Parecoxib, valdecoxib, and cardiovas-cular risk. Circulation 222:249, 2005.
26. Nussmeier NA, Whelton AA, Brown MT, Langford RM, Hoeft A, Parlow JL, Boyce SW, Verburg KM: Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N Engl J Med 352:1081-1091, 2005.
27. Malan TP Jr, Gordon S, Hubbard R, Snabes M: The cyclooxygenase-2-specific inhibitor parecoxib sodium is as effective as 12 mg of morphine administered intramuscularly for treating pain after gynecological laparotomy surgery. Anesth Analg 100:454-460, 2005.
28. Bikhazi GB, Snabes MC, Bajwa ZH, Davis DJ, LeComte D, Taylor L, Hubbard RC: A clinical trial demonstrates the analgesic activity of intravenous parecoxib sodium compared with ketorolac or morphine after gynecological surgery with laparotomy. Am J Obstet Gynecol 191:1183-1191, 2004.
29. Schelzig H, Sunder-Plassmann L, Träger K, Georgieff M, Radermacher P, Fröba G: Ischämie- und reperfusion des intestinalen und hepatischen stromgebiets bei thorakalen crossclamping. Gefässchirurgie 8:92-99, 2003.
30. Vassilev D, Hauser B, Iványi Z, Schoaff M, Asfar P, Vogt J, Wachter U, Schelzig H, Georgieff M, Brücker UB, Radermacher P, Fröba G: Systemic and hepatosplanchnic effects of N-acetylcysteine during long-term porcine endotoxemia. Crit Care Med 32:525-532, 2004.
31. Breckwoldt WL, Mackey WC, Belkin M, O'Donnel TF: The effect of suprarenal cross-clamping on abdominal aortic repair. Arch Surg 127:520-524, 1992.
32. Nichols AB, Owen J, Grossman-Marcella JJ, Fleisher LN, Lee MM: Effect of heparin bonding on catheter-induced fibrin formation and platelet activation. Circulation 7:843-850, 1984.
33. Miller Q, Peyton BD, Cohn EJ, Holmes GF, Harlin SA, Bird ET, Harre JG, Miller ML, Riley KD, Hogan MB, Taylor A: The effects of intraoperative fenoldopam on renal blood flow and tubular function following suprarenal aortic cross-clamping. Ann Vasc Surg 17:656-662, 2003.
34. Cheng HF, Harris RC: Cyclooxygenases, the kidney, and hypertension. Hypertension 43:525-530, 2004.
35. Ray WA, Griffin MR, Stein CM: Cardiovascular toxicity of valdecoxib. N Engl J Med 351:2767, 2004.